Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1988 1
1995 1
1996 1
1998 1
2000 2
2001 2
2003 3
2004 4
2005 5
2006 3
2007 5
2008 3
2009 1
2010 3
2011 5
2012 9
2013 4
2014 3
2015 1
2016 3
2017 3
2018 6
2019 3
2020 5
2021 5
2022 4
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.
Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Konstantinides SV, et al. Among authors: agnelli g. Eur Heart J. 2014 Nov 14;35(43):3033-69, 3069a-3069k. doi: 10.1093/eurheartj/ehu283. Epub 2014 Aug 29. Eur Heart J. 2014. PMID: 25173341 Free article. No abstract available.
Guidance for the treatment of deep vein thrombosis and pulmonary embolism.
Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes R, McBane RD, Moll S, Ansell J. Streiff MB, et al. Among authors: agnelli g. J Thromb Thrombolysis. 2016 Jan;41(1):32-67. doi: 10.1007/s11239-015-1317-0. J Thromb Thrombolysis. 2016. PMID: 26780738 Free PMC article. Review.
The optimal duration of therapy is dictated by the presence of modifiable thrombotic risk factors. Long term anticoagulation should be considered in patients with unprovoked VTE as well as persistent prothrombotic risk factors such as cancer. Short-term therapy is s …
The optimal duration of therapy is dictated by the presence of modifiable thrombotic risk factors. Long term anticoagulation should b …
Oral rivaroxaban for symptomatic venous thromboembolism.
EINSTEIN Investigators; Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S. EINSTEIN Investigators, et al. Among authors: agnelli g. N Engl J Med. 2010 Dec 23;363(26):2499-510. doi: 10.1056/NEJMoa1007903. Epub 2010 Dec 3. N Engl J Med. 2010. PMID: 21128814 Free article. Clinical Trial.
CONCLUSIONS: Rivaroxaban offers a simple, single-drug approach to the short-term and continued treatment of venous thrombosis that may improve the benefit-to-risk profile of anticoagulation. ...
CONCLUSIONS: Rivaroxaban offers a simple, single-drug approach to the short-term and continued treatment of venous thrombosis that ma …
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
EINSTEIN–PE Investigators; Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A. EINSTEIN–PE Investigators, et al. Among authors: agnelli g. N Engl J Med. 2012 Apr 5;366(14):1287-97. doi: 10.1056/NEJMoa1113572. Epub 2012 Mar 26. N Engl J Med. 2012. PMID: 22449293 Free article. Clinical Trial.
CONCLUSIONS: A fixed-dose regimen of rivaroxaban alone was noninferior to standard therapy for the initial and long-term treatment of pulmonary embolism and had a potentially improved benefit-risk profile. ...
CONCLUSIONS: A fixed-dose regimen of rivaroxaban alone was noninferior to standard therapy for the initial and long-term treatment of …
Contemporary Management and Clinical Course of Acute Pulmonary Embolism: The COPE Study.
Becattini C, Agnelli G, Maggioni AP, Dentali F, Fabbri A, Enea I, Pomero F, Ruggieri MP, di Lenarda A, Cimini LA, Pepe G, Cozzio S, Lucci D, Gulizia MM; COPE Investigators. Becattini C, et al. Among authors: agnelli g. Thromb Haemost. 2023 Jun;123(6):613-626. doi: 10.1055/a-2031-3859. Epub 2023 Feb 9. Thromb Haemost. 2023. PMID: 36758612 Free PMC article.
BACKGROUND: New diagnosis, risk stratification, and treatment strategies became recently available for patients with acute pulmonary embolism (PE) leading to changes in clinical practice and potentially influencing short-term patients' outcomes. RESEARCH QUESTION: The COnt …
BACKGROUND: New diagnosis, risk stratification, and treatment strategies became recently available for patients with acute pulmonary embolis …
Acute treatment of venous thromboembolism.
Becattini C, Agnelli G. Becattini C, et al. Among authors: agnelli g. Blood. 2020 Jan 30;135(5):305-316. doi: 10.1182/blood.2019001881. Blood. 2020. PMID: 31917399 Free article. Review.
Initial anticoagulant treatment is crucial for reducing mortality, preventing early recurrences, and improving long-term outcome. Treatment and patient disposition should be tailored to the severity of clinical presentation, to comorbidities, and to the potential to receiv …
Initial anticoagulant treatment is crucial for reducing mortality, preventing early recurrences, and improving long-term outcome. Tre …
Perioperative stroke risk in nonvascular surgery.
Macellari F, Paciaroni M, Agnelli G, Caso V. Macellari F, et al. Among authors: agnelli g. Cerebrovasc Dis. 2012;34(3):175-81. doi: 10.1159/000339982. Epub 2012 Aug 22. Cerebrovasc Dis. 2012. PMID: 22922182 Free article. Review.
This relatively rare complication deserves attention because of its high mortality and serious disability, the latter of which can lead to prolonged hospital stay as well as discharge to long-term care facilities. The aim of this article was to review the literature on per …
This relatively rare complication deserves attention because of its high mortality and serious disability, the latter of which can lead to p …
Current issues in anticoagulation.
Agnelli G. Agnelli G. Pathophysiol Haemost Thromb. 2005;34 Suppl 1:2-9. doi: 10.1159/000083078. Pathophysiol Haemost Thromb. 2005. PMID: 15812198 Free article. Review.
With its oral formulation, consistent and predictable pharmacological profile and no coagulation monitoring, ximelagatran has the potential to increase the use and duration of anticoagulation treatment in thromboembolic disorders and to reduce the burden associated with long-t …
With its oral formulation, consistent and predictable pharmacological profile and no coagulation monitoring, ximelagatran has the potential …
Edoxaban: a focused review of its clinical pharmacology.
Lip GY, Agnelli G. Lip GY, et al. Among authors: agnelli g. Eur Heart J. 2014 Jul 21;35(28):1844-55. doi: 10.1093/eurheartj/ehu181. Epub 2014 May 8. Eur Heart J. 2014. PMID: 24810388 Review.
Long-term anticoagulation treatment with warfarin has been associated with a number of limitations in clinical practice and there is a need for more convenient long-term anticoagulation treatment. ...In conclusion, the pharmacological properties of edoxaban provide …
Long-term anticoagulation treatment with warfarin has been associated with a number of limitations in clinical practice and there is …
Definition of major bleeding: Prognostic classification.
Franco L, Becattini C, Beyer-Westendorf J, Vanni S, Nitti C, Re R, Manina G, Pomero F, Cappelli R, Conti A, Agnelli G. Franco L, et al. Among authors: agnelli g. J Thromb Haemost. 2020 Nov;18(11):2852-2860. doi: 10.1111/jth.15048. Epub 2020 Sep 11. J Thromb Haemost. 2020. PMID: 32767653 Free article.
However, this definition identifies MBs with highly variable short-term risk of death. OBJECTIVES: The study aims were to derive and validate a classification of ISTH-defined MBs for the risk of short-term death. ...A prognostic classification of ISTH-defined MBs fo …
However, this definition identifies MBs with highly variable short-term risk of death. OBJECTIVES: The study aims were to derive and …
85 results